1. Agus DB, Bunn PA. et al. (2000) HER-2/neu as a therapeutic target in non-small cell lung cancer. prostate cancer. and ovarian cancer. Semin Oncol 27(Suppl 11):53–63
2. Akerley W, Herndon J, Turrisi A. et al. (2000) Induction chemotherapy with paclitaxel and carboplatin followed by concurrent thoracic radiation and weekly PC for patients with unresectable sectable stage III non-small cell lung cancer (NSCLC):preliminary analysis of a phase II trial by the CALGB. Proc Am Soc Clin Oncol 19:490a (Abstract 1915)
3. Albain JJ, Crowley AT, Turrisi DR. et al. (1997) Concurrent cisplatin/ etoposide plus radiotherapy (PE+RT) for pathologic stage (pathTN) IIIB non-small cell lung cancer (NSCLC): a South west Oncology Group (SWOG) phase II study (S9019). Proc Am Soc Clin Oncol 16: 446a (Abstract #1600)
4. Anderson H, Thatcher N, Walling J. et al. (1994) Gemcitabine and palliation of symptoms in non-small cell lung cancer. Proc Am Soc Clin Oncol 13: 367a (Abstract #1238)
5. Andre F, Grunewald D, Pignon JP, et al. (2000) Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 18:2981–2989